Related Articles
Comparative proteomics identify HSP90A, STIP1 and TAGLN‑2 in serum extracellular vesicles as potential circulating biomarkers for human adenomyosis
Anti‑proliferative action of IL‑6R-targeted antibody tocilizumab for non-small cell lung cancer cells
Differential expression and inhibitory effects of aquaporins on the development of adenomyosis
JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway
Interleukin-12-anchored exosomes increase cytotoxicity of T lymphocytes by reversing the JAK/STAT pathway impaired by tumor-derived exosomes